Nautilus Biotechnology, Inc. — Form D

Nautilus Biotechnology, Inc. of SEATTLE, WA, a company, filed a Form D exempt-offering notice with the SEC on 2021-06-22. The offering totals $200.0M, of which $200.0M was reported sold. Industry: Other.

Offering

• Filed: 2021-06-22
• Form: D
• Accession: 0001741638-21-000002
• Industry: Other
• Exemptions: 06b
• Total offering: $200.0M
• Amount sold: $200.0M
• Investors: 38
• Date of first sale: 2021-06-09
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-403839

Issuer

• Name: Nautilus Biotechnology, Inc.
• CIK: 0001808805
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2020
• Address: 425 PONTIUS AVE N, STE 202, SEATTLE, WA, 98109
• Phone: 206-333-2001

Officers, directors & promoters (14)

More

• CIK 1808805 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search